Edition:
United States

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

2.15USD
25 Sep 2018
Change (% chg)

-- (--)
Prev Close
$2.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,233
52-wk High
$3.92
52-wk Low
$1.16

Chart for

About

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral... (more)

Overall

Beta: 1.32
Market Cap(Mil.): $43.05
Shares Outstanding(Mil.): 20.60
Dividend: --
Yield (%): --

Financials

  BIOL.OQ Industry Sector
P/E (TTM): 8.54 48.29 32.55
EPS (TTM): 0.24 -- --
ROI: 11.41 8.54 12.80
ROE: 11.88 12.26 14.92

BRIEF-Biolase Announces 1-For-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11

* BIOLASE ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON MAY 11

May 10 2018

BRIEF-Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives

* HAS ASKED JONATHAN T. LORD CHAIRMAN OF BOARD OF BIOLASE, TO LEAD CO'S EXPLORATION OF STRATEGIC ALTERNATIVES

Apr 11 2018

BRIEF-Biolase Names Garrett Sato To Board Of Directors

* ADDITION OF SATO INCREASES SIZE OF BOARD TO FIVE DIRECTORS Source text for Eikon: Further company coverage:

Apr 04 2018

Earnings vs. Estimates